ArticleTranslational pediatrics2025
The development and validation of a privacy-preserving model based on federated learning for diagnosing severe pediatric pneumonia.
Article in Translational pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: There is a challenge of in diagnostic testing of pneumonia in children, especially severe pneumonia. Thus, developing an auxiliary diagnostic model to help identify severe pneumonia in pediatric patients at an early stage would be highly valuable to address the issues. To overcome the issue of privacy protection, we applied a privacy-preserving machine learning framework to build a multicenter diagnostic model based on federated learning technology. Methods: Based on Arya, a novel privacy computing platform developed by Hangzhou Healink Technology Corporation, several privacy-preserving federated learning models were developed using datasets from one, two, or four medical centers. A total of 5,091 records were included in this multicenter retrospective study, with 2,484 pediatric patients with severe pneumonia and 2,607 with common pneumonia. Among the records, 80% were used in model training for the diagnosis of severe pneumonia, with 11 common indicators, including white blood cell count (WBC), high-sensitivity C-reactive protein (hs-CRP), hemoglobin (Hb), platelet count (PLT), lymphocyte percentage (L%), monocyte percentage (M%), neutrophil percentage (N%), prothrombin time (PT), alanine aminotransferase (ALT), aspartate aminotransferase (AST), and lactic dehydrogenase (LDH), while the other 20% records were used for model efficacy evaluation. During the process, the original data were stored in the individual hospitals without transmission. Results: Based on privacy-preserving federated learning technology, the developed models provided reliable diagnostic efficacy for severe pneumonia. Among these models, the four-center model achieved the highest diagnostic efficacy (95.10% sensitivity, 82.70% specificity, and 85.80% accuracy). Although the two-center models achieved a relatively low diagnostic efficacy, they still surpassed the diagnostic efficacy of the single-center model (88.10% sensitivity, 74.60% specificity, and 81.00% accuracy). Conclusions: Privacy-preserving federated learning technology can facilitate the performance of multicenter studies and was used to develop a high-performance diagnostic model for severe pneumonia in pediatric patients, which can benefit doctors and patients as an auxiliary diagnostic tool.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.